Apixaban showed superior safety and lower risk for major bleeding than both warfarin and rivaroxaban among older adult patients with HIV and AF.

Thanks to hefty sales increases from kidney disease drug Kerendia and prostate cancer treatment Nubeqa, Bayer’s pharma ...

Bayer chief executive Bill Anderson has said that newer product launches have offset the decline in sales of anticoagulant ...